Hyperfine (NASDAQ:HYPR) Price Target Cut to $1.20 by Analysts at B. Riley

Hyperfine (NASDAQ:HYPRFree Report) had its target price trimmed by B. Riley from $1.50 to $1.20 in a report issued on Thursday morning,Benzinga reports. The firm currently has a buy rating on the stock.

Separately, Wells Fargo & Company lifted their price target on shares of Hyperfine from $1.10 to $1.29 and gave the company an “equal weight” rating in a research note on Tuesday.

View Our Latest Research Report on Hyperfine

Hyperfine Stock Up 1.4 %

HYPR opened at $0.86 on Thursday. Hyperfine has a twelve month low of $0.76 and a twelve month high of $1.90. The company has a fifty day moving average of $1.07 and a 200-day moving average of $1.01. The stock has a market cap of $62.91 million, a PE ratio of -1.51 and a beta of 0.94.

Hyperfine (NASDAQ:HYPRGet Free Report) last posted its quarterly earnings data on Monday, March 17th. The company reported ($0.14) earnings per share for the quarter, topping the consensus estimate of ($0.16) by $0.02. Hyperfine had a negative net margin of 309.42% and a negative return on equity of 57.54%. The company had revenue of $2.32 million during the quarter, compared to analysts’ expectations of $2.30 million. During the same period in the prior year, the company posted ($0.15) earnings per share. Sell-side analysts anticipate that Hyperfine will post -0.57 EPS for the current fiscal year.

Institutional Investors Weigh In On Hyperfine

Several hedge funds and other institutional investors have recently bought and sold shares of HYPR. Geode Capital Management LLC increased its stake in Hyperfine by 18.7% in the third quarter. Geode Capital Management LLC now owns 624,520 shares of the company’s stock valued at $675,000 after purchasing an additional 98,335 shares in the last quarter. Graypoint LLC acquired a new position in shares of Hyperfine during the fourth quarter valued at about $44,000. Virtu Financial LLC acquired a new position in shares of Hyperfine during the fourth quarter valued at about $25,000. Renaissance Technologies LLC grew its holdings in shares of Hyperfine by 32.9% during the fourth quarter. Renaissance Technologies LLC now owns 212,300 shares of the company’s stock valued at $187,000 after buying an additional 52,500 shares during the last quarter. Finally, Wealth Enhancement Advisory Services LLC grew its holdings in shares of Hyperfine by 64.3% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 82,008 shares of the company’s stock valued at $72,000 after buying an additional 32,093 shares during the last quarter. 15.03% of the stock is owned by institutional investors.

Hyperfine Company Profile

(Get Free Report)

Hyperfine, Inc, a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors.

Further Reading

Receive News & Ratings for Hyperfine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hyperfine and related companies with MarketBeat.com's FREE daily email newsletter.